IntroductionModafinil is a wakefulness-selling agent primarily used to treat sleep disorders equivalent to narcolepsy, obstructive sleep apnea, and shift work sleep disorder. Its rising recognition as a cognitive enhancer has led to a rise in online consultations for acquiring prescriptions. This report explores the implications, benefits, challenges, and regulatory considerations
